Neuraxpharm
Climate Impact & Sustainability Data (2021-22)
Reporting Period: 2021-22
Environmental Metrics
Total Carbon Emissions:2383 tCO2e (2021)
Scope 1 Emissions:678 tCO2e (2021)
Scope 2 Emissions:1268 tCO2e (2021)
Total Energy Consumption:9132 MWh (2021)
Water Consumption:34700 m3 (2021)
Waste Generated:1249 tons (2021)
ESG Focus Areas
- Mental health and well-being
- Diversity & Inclusion
- Environmental Management & Climate Action
- Responsible Sourcing
- Governance, Compliance & Ethics
Environmental Achievements
- Reduction of CO2 emissions
- Reduction of travel miles
- Implementation of energy and water consumption reduction initiatives
- Finalised installation of photovoltaic panels in two production sites
- Replacement of brine unit with new equipment operating with VFD technology and lower GWP at Inke plant
- Gradual replacement of non-LED lights with LEDs at Inke site
- Replacement of fluorescent lights with LED lights at Lesvi production site
- Introduction of hybrid cars for salesforce
- Rollout of e-signature tool to reduce paper consumption
Social Achievements
- Developed helpful materials for CNS healthcare professionals, patients and families
- Launched ‘A kiss for mental health’ campaign, raising over EUR 4,500 for Fundación Querer
- Launched ‘Life-changing Minutes’ digital initiative to raise epilepsy awareness
- Donated pharmaceuticals worth >€1,800,000 to Ukrainian medical facilities and organisations supporting Ukrainian refugees
- Implemented NeuraxLearner Program for internships/apprenticeships
- Implemented NeuraxGolden Program for senior candidates
- Established weekly sport/wellness activities
- Rolled out Flex Office 2.0 policy
- Implemented ‘How to Celebrate Success’ training for managers
- Launched Employee Referral Program
- Launched Inclusion Suggestion Box
- 80+ internal promotions/lateral appointments in 2021-2022
Governance Achievements
- Defined and performed an annual Compliance training plan
- Implemented Whistleblowing channel available for third parties
- Implementation of acceptance of Code of Ethics by third parties
- Launched Compliance training platform with >75% employee participation
- Developed a Senior Management commitment protocol
Climate Goals & Targets
Short-term Goals:
- Extend support for mental health and raise awareness of CNS disorders in more countries
- Increase usage of Coursera
- Implement Inclusive Box
- Design and roll out Neuraxpharm Leadership Standards
- Redesign values & behaviours
- Keep up regular well-being activities
- Roll out Flex Office 3.0 policy
- Roll out new well-being measures
- Conduct biannual survey of key suppliers
- Develop Senior Management commitment protocol
- Develop new annual Compliance training (>75% participation)
- Implement acceptance of Code of Ethics by third parties
Environmental Challenges
- War in Ukraine and resulting energy price increases
- Global supply chain shortages
Mitigation Strategies
- Donated pharmaceuticals to Ukraine
- Continued to explore ways to support Ukrainian people
- Implemented resilience measures
- Focused on evolving and innovating to overcome challenges
- Implemented supplier code of conduct and biannual survey to mitigate supply chain risks
Supply Chain Management
Supplier Audits: Biannual survey of key suppliers (starting in 2022)
Responsible Procurement
- Supplier code of conduct
- Contingency Plan Questionnaire
- GMP compliance requirements
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: UN Sustainable Development Goals (SDGs)
Certifications: ISO 14001:2015 (Inke plant)
UN Sustainable Development Goals
- SDG 3: Good Health and Well-being
- SDG 8: Decent Work and Economic Growth
- SDG 13: Climate Action
Neuraxpharm's operations contribute to these goals through its focus on CNS health, employee well-being, and environmental sustainability initiatives.